Ribaxamase

N/A

Report date: 2024/04/18 15:14:56

Base Information

Drug NameRibaxamase
Drug Alias NameBacillus licheniformis isoenzymeKymeraseSYN-007P3ASYN-004 (Theriva Biologics)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionGastrointestinal microbiome modulatorsToxin B inhibitorsBeta Lactamase replacements
TargetsToxin BBeta Lactamase
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIpsat Therapies
China Registration ClassN/A

Develop Information

Active CompaniesTheriva Biologics Inc
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A